Type of information: Nomination
Company: Inovio Pharmaceuticals (USA - PA)
Therapeutic area: Cancer - Oncology - Infectious diseases
Type agreement: nomination
- • On June 28, 2017, Inovio Pharmaceuticals announced leadership appointments to support its growth and expanding strategic and operational initiatives.
- Inovio promoted Dr. Keiko Simon to Vice President, Alliance and Program Management and Jeffrey C. Richardson to Vice President, Strategic Relations.
- Dr. Simon, who joined Inovio in 2013, will be responsible for managing the company’s relationships with its external partners including product development collaborations with MedImmune, Regeneron, and Genentech, and other collaborations. She also will direct internal project management of Inovio’s pipeline programs in development including its phase 3 program. She joined Inovio after a 20-year career at Merck in project and portfolio management, supporting the infectious disease and vaccine therapeutic areas and external partnerships.
- Jeffrey C. Richardson joined Inovio in 2012 after serving Amgen and GSK in global communications positions. He will be responsible for directing Inovio’s media relations, human resources, government affairs and executive communications efforts.